Hugo Jourdain

6PUBLICATIONS
10CO-AUTHORS
PharmacogenomicsConsumer-oriented product or service developmentInfant and child healthEpidemiological methodsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 03, 2026
Trends and Characteristics of Opioid Use During Pregnancy Between 2010 and 2023: A French Nationwide Drug Utilization Study.

|Feb 10, 2025
Use of Semaglutide (Wegovy) in Adults in France: A Nationwide Drug Utilization Study.

Nadia Haddy, Hugo Jourdain, David Desplas

|Jan 23, 2025
Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases: an observational longitudinal study on the French National Health Data System.

Hugo Jourdain, Léa Hoisnard, Emilie Sbidian

|Oct 07, 2024
Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric Cancer in a Real-World Setting: A Nationwide Cohort Study.

Hugo Jourdain, Nicolas Albin, Adrien Monard

|Mar 07, 2024
Persistence and safety of anti-TNF biosimilars versus originators in immune-mediated inflammatory diseases: an observational study on the French National Health Data System.

Hugo Jourdain, Léa Hoisnard, Emilie Sbidian

|Mar 06, 2023
Severe Hypersensitivity Reactions at Biosimilar versus Originator Rituximab Treatment Initiation, Switch and Over Time: A Cohort Study on the French National Health Data System.

Hugo Jourdain, Léa Hoisnard, Emilie Sbidian

Pageof 1

Frequent Collaborators

3 joint publications

Mahmoud Zureik

1 joint publications

Léa Hoisnard

1 joint publications

Emilie Sbidian

1 joint publications

Nadia Haddy